Pioneering Progress: The Evolution of Dermatology at Incyte

As we approach this year’s American Academy of Dermatology (AAD) Annual Meeting, we are proud to showcase our investigational pipeline through studies across many disease areas and reflect on the evolution of our work in the field.

Rooted in our heritage and expertise in immunology, the start of our efforts in Dermatology marked the beginning of an exciting new chapter for Incyte. Since then, our research and development teams have been focused on advancing new treatment options for people living with immune-mediated dermatologic conditions.

Exploring the therapeutic potential of key pathways and signaling mechanisms within the body's immune system to identify new ways to target and treat a variety of immune-mediated dermatologic conditions has been at the forefront of our research.

In addition to important progress made to introduce new and first-ever treatments for patients living with AD and vitiligo, respectively, we are expanding our efforts to address additional diseases and explore new therapies for other inflammatory skin conditions including:

  • Prurigo nodularis (PN): A chronic condition that causes itchy bumps on the skin called “nodules” that appear after excessive scratching. It typically occurs on the arms, legs and trunk of the body.
  • Hidradenitis suppurativa (HS): Also known as acne inversa, HS is a difficult to treat condition that causes red, painful bumps typically in the armpits and groin.
  • Lichen planus: A chronic disorder that causes itchy and purple bumps or plaques on the skin that may also present on the nails and in the mouth.

Every day, our unwavering resolve is to Solve On. for patients living with challenging conditions. Whether in Dermatology or in our other focus areas, including Oncology and Inflammation & Autoimmunity, patients are our greatest motivators.

Innovating for Tomorrow
Patients Inspire Our Science: Meet Leonard & Indu